Payment overview · 2025
General Payments
$36.37
4 reported records · 3 companies
Healthcare provider profile · identity verified
Kara Danielle Wyatt, MD
Allopathic & Osteopathic Physicians|Family Medicine · MUNCIE, IN · NPI 1245675099
Verified facts
What the public records show
CMS Open Payments records show Kara Danielle Wyatt, MD received $36.37 in general payments during 2025 across 4 reported records.
Inspire Medical Systems, Inc. accounted for 42.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $15.56 | 42.8% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $13.93 | 38.3% | 2 | 2025 |
| Corium, LLC | Unresolved — no canonical attribution shown | $6.88 | 18.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.37 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $15.56 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $13.93 | 2 | 2025 |
Source payment records
|
|||||
| Azstarys Normalized: azstarys |
Drug | Corium, LLC | $6.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 450 | 125 |
| Levothyroxine Sodium | Levothyroxine Sodium | 342 | 81 |
| Lisinopril | Lisinopril | 302 | 89 |
| Amlodipine Besylate | Amlodipine Besylate | 274 | 79 |
| Gabapentin | Gabapentin | 248 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 241 | 60 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 220 | 42 |
| Omeprazole | Omeprazole | 198 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 192 | 53 |
| Furosemide | Furosemide | 174 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 166 | 42 |
| Alendronate Sodium | Alendronate Sodium | 143 | 34 |
| Hydrochlorothiazide | Hydrochlorothiazide | 143 | 43 |
| Trazodone Hcl | Trazodone Hcl | 127 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 124 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 119 | 24 |
| Losartan Potassium | Losartan Potassium | 116 | 35 |
| Potassium Chloride | Potassium Chloride | 116 | 35 |
| Metformin Hcl | Metformin Hcl | 112 | 32 |
| Alprazolam | Alprazolam | 108 | 15 |
| Montelukast Sodium | Montelukast Sodium | 107 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 103 | 31 |
| Tramadol Hcl | Tramadol Hcl | 99 | 24 |
| Fenofibrate | Fenofibrate | 98 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 97 | 20 |
| Sertraline Hcl | Sertraline Hcl | 96 | 22 |
| Tamsulosin Hcl | Tamsulosin Hcl | 95 | 28 |
| Valsartan | Valsartan | 95 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 93 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 89 | 16 |
| Metformin Hcl Er | Metformin Hcl | 88 | 30 |
| Simvastatin | Simvastatin | 83 | 23 |
| Jardiance | Empagliflozin | 81 | 23 |
| Ezetimibe | Ezetimibe | 75 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 72 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 70 | 16 |
| Glimepiride | Glimepiride | 70 | 25 |
| Buspirone Hcl | Buspirone Hcl | 69 | 21 |
| Donepezil Hcl | Donepezil Hcl | 69 | 15 |
| Eliquis | Apixaban | 66 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 18 |
| Carvedilol | Carvedilol | 59 | 19 |
| Mounjaro | Tirzepatide | 58 | 14 |
| Ozempic | Semaglutide | 58 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 58 | 18 |
| Prednisone | Prednisone | 58 | 47 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 56 | 12 |
| Celecoxib | Celecoxib | 55 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 54 | 15 |
| Famotidine | Famotidine | 53 | 16 |
| Methylprednisolone | Methylprednisolone | 51 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 51 | 15 |
| Atenolol | Atenolol | 47 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 45 | suppressed |
| Meloxicam | Meloxicam | 42 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 42 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 42 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 42 | suppressed |
| Nystatin | Nystatin | 40 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 37 | 11 |
| Azithromycin | Azithromycin | 36 | 34 |
| Myrbetriq | Mirabegron | 36 | suppressed |
| Estradiol | Estradiol | 35 | 14 |
| Pregabalin | Pregabalin | 35 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 24 |
| Spironolactone | Spironolactone | 33 | suppressed |
| Aripiprazole | Aripiprazole | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Mirtazapine | Mirtazapine | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 16 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 31 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 29 | suppressed |
| Rybelsus | Semaglutide | 29 | suppressed |
| Allopurinol | Allopurinol | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Clonazepam | Clonazepam | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | 17 |
| Baclofen | Baclofen | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Fluconazole | Fluconazole | 24 | 16 |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Mupirocin | Mupirocin | 23 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Synthroid | Levothyroxine Sodium | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | suppressed |
| Acyclovir | Acyclovir | 21 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 17 |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 15 |
| Glipizide | Glipizide | 19 | suppressed |
| Lorazepam | Lorazepam | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 15 |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Klor-Con M20 | Potassium Chloride | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Acetazolamide | Acetazolamide | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Finasteride | Finasteride | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Phenytoin | Phenytoin | 13 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 13 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 11 |
| Lidocaine | Lidocaine | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.37 · 4 records | Inspire Medical Systems, Inc. | Azstarys, INSPIRE, VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error